Immutics inc
WitrynaDongxu Sun's business email address is d**@immutics.com. What is Dongxu Sun's HQ phone number? Dongxu Sun's HQ phone number is +1(650) 847-1117. What industry does Dongxu Sun work in? Dongxu Sun works in the Research industry. Who are Dongxu Sun's colleagues? Witryna7 lis 2024 · Free and open company data on California (US) company TRUEBINDING, INC. (company number 4082118), 1140A O'BRIEN DRIVE MENLO PARK CA 94025-1411. The Open Database Of The Corporate World. Search. Companies Officers ... IMMUTICS, INC. (Delaware (US), 27 Oct 2024 - ) details: TRUEBINDING, INC. …
Immutics inc
Did you know?
Witryna30 lip 2024 · Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation for cell line engineering, today announced that TrueBinding, Inc. (formerly Immutics, Inc.), a biopharmaceutical company, has signed a set of commercial licences for Horizon’s cGMP-compliant CHOSOURCE™ platform. WitrynaOperating Status Active. Last Funding Type Corporate Round. Also Known As Immutics. Legal Name TrueBinding Inc. Company Type For Profit. Contact Email …
WitrynaImmatics US, Inc. 2201 W. Holcombe Blvd., Suite 205 Houston, Texas 77030. Business line: +1 346 204-5400 Fax line: +1 346 204-5931 E-Mail: [email protected]. … Witryna29 lip 2024 · Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation for cell line engineering ...
WitrynaTrueBinding. Overview. Researching and developing first-in-class monoclonal antibody drugs to treat tumor, fibrotic diseases, metabolic diseases, autoimmune diseases and neurologic diseases. WitrynaTrueBinding (formerly known as Immutics) is a biotherapeutics development company. It focuses on creating molecules for applications in immuno oncology and other disease areas.
WitrynaImmutics Inc is a company that operates in the Biotechnology industry. It employs 11-20 people and has $0M-$1M of revenue. The company is headquartered in Menlo Park, …
Witryna29 lip 2024 · CAMBRIDGE, England, & MENLO PARK, Calif.--(BUSINESS WIRE)-- Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation for cell line engineering, today announced that TrueBinding, Inc. (“TrueBinding”, formerly … \u0027sdeath n9WitrynaImmutics, Inc. Funding details. Immutics, Inc. raised $19,746,137 from 1 investor on 2024-10-21. Who is raising money? Immutics, Inc. Funding details Immutics, Inc. … \u0027sdeath naWitryna29 lip 2024 · TrueBinding signs multi-product commercial-use license to develop stable, antibody-expressing cell lines using Horizon’s gene-edited CHO GS knockout platform ... February 12, 2024 \u0027sdeath neWitryna3 lis 2024 · TrueBinding, Inc. - Most recent fund raising on November 3, 2024 raised $20,100,005 in Equity and Debt \u0027sdeath niWitrynaImmutics, Inc. Street Address 1 Street Address 2; 1140A O'BRIEN DR. City State/Province/Country ZIP/PostalCode Phone Number of Issuer; MENLO PARK: CALIFORNIA: 94025 (650) 847-1117: 3. Related Persons. Last Name First Name Middle Name; Sun: Dongxu: Street Address 1 Street Address 2; 1140A O'Brien Dr. City … \u0027sdeath nfWitrynaImmatics US, Inc. 2201 W. Holcombe Blvd., Suite 205 Houston, Texas 77030. Business line: +1 346 204-5400 Fax line: +1 346 204-5931 E-Mail: [email protected]. … \u0027sdeath ncWitrynaImmutics, Inc. Treating cancer by blocking the interaction of tim-3 and its ligand US20240175649A1 (en) * 2016-02-18: 2024-06-13: Enlivex Therapeutics Ltd: Combination immune therapy and cytokine control therapy for cancer treatment WO2024152895A1 (en) * 2024-02-01: 2024-08-08: Memorial Sloan Kettering Cancer … \u0027sdeath nn